-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Share
Listen to the news

Gainers

  • Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 14.6% to $3.3 during Tuesday's pre-market session. The company's market cap stands at $14.4 million.
  • Pomdoctor (NASDAQ:POM) stock moved upwards by 13.27% to $1.28. The company's market cap stands at $3.1 million.
  • Kiniksa Pharmaceuticals (NASDAQ:KNSA) stock moved upwards by 12.33% to $81.98. The company's market cap stands at $5.6 billion. As per the news, the Q3 earnings report came out today.
  • Lucid Diagnostics (NASDAQ:LUCD) stock rose 9.84% to $0.55. The company's market cap stands at $95.6 million.
  • Pluri (NASDAQ:PLUR) shares moved upwards by 9.81% to $1.23. The market value of their outstanding shares is at $14.1 million.
  • Tessera Defense (AMEX:HLSQ) stock increased by 9.24% to $0.23. The market value of their outstanding shares is at $1.9 million.

Losers

  • SciSparc (NASDAQ:SPRC) shares declined by 34.9% to $0.84 during Tuesday's pre-market session.
  • Actuate Therapeutics (NASDAQ:ACTU) shares declined by 29.73% to $0.37. The market value of their outstanding shares is at $12.6 million.
  • Artiva Biotherapeutics (NASDAQ:ARTV) stock fell 22.89% to $4.75. The company's market cap stands at $301.1 million.
  • Imunon (NASDAQ:IMNN) shares decreased by 18.55% to $1.0. The company's market cap stands at $6.9 million.
  • Onconetix (NASDAQ:ONCO) stock decreased by 16.57% to $0.33. The company's market cap stands at $1.7 million.
  • Lakewood-Amedex (NASDAQ:LABT) stock declined by 11.81% to $0.25. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending